• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)

    2/13/23 5:14:53 PM ET
    $SFE
    Finance/Investors Services
    Finance
    Get the next $SFE alert in real time by email
    SC 13G/A 1 d467769dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

     

    SCHEDULE 13G

    (Rule 13d-102)

    (Amendment No. 1)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

    RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO RULE 13d-2

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    Safeguard Scientifics, Inc.

    (Name of Issuer)

    Common Stock, $0.10 par value

    (Title of Class of Securities)

    786449207

    (CUSIP Number)

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

     

     


    CUSIP No. 786449207

     

      1    

      NAME OF REPORTING PERSONS

     

      North Run Capital, LP

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      252,728*

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      252,728**

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      252,728**

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      1.5%**

    12  

      TYPE OF REPORTING PERSON*

     

      PN

     

    *

    SEE INSTRUCTIONS BEFORE FILLING OUT

    **

    SEE ITEM 4.


    CUSIP No. 786449207

     

      1    

      NAME OF REPORTING PERSONS

     

      North Run Advisors, LLC

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      252,728**

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      252,728**

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      252,728**

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      1.5%**

    12  

      TYPE OF REPORTING PERSON*

     

      OO

     

    *

    SEE INSTRUCTIONS BEFORE FILLING OUT

    **

    SEE ITEM 4.


    CUSIP No. 786449207

     

      1    

      NAME OF REPORTING PERSONS

     

      Todd B. Hammer

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      United States

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      252,728**

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      252,728**

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      252,728**

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      1.5%**

    12  

      TYPE OF REPORTING PERSON*

     

      IN

     

    *

    SEE INSTRUCTIONS BEFORE FILLING OUT

    **

    SEE ITEM 4.


    CUSIP No. 786449207

     

      1    

      NAME OF REPORTING PERSONS

     

      Thomas B. Ellis

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      United States

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      252,728**

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      252,728**

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      252,728**

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      1.5%**

    12  

      TYPE OF REPORTING PERSON*

     

      IN

     

    *

    SEE INSTRUCTIONS BEFORE FILLING OUT

    **

    SEE ITEM 4.


    AMENDMENT NO. 1 TO SCHEDULE 13G

    This Amendment No. 1 to Schedule 13G (this “Amendment”) is being filed on behalf of North Run Capital, LP, a Delaware limited partnership (the “Investment Manager”), North Run Advisors, LLC, a Delaware limited liability company (“North Run”), Todd B. Hammer and Thomas B. Ellis (collectively, the “Reporting Persons”). Todd B. Hammer and Thomas B. Ellis are the principals and sole members of North Run. North Run is the general partner of the Investment Manager. The Investment Manager is the investment manager of certain private pooled investment vehicles (collectively, the “Funds”). This Amendment relates to shares of Common Stock, $0.10 par value (the “Common Stock”), of Safeguard Scientifics, Inc., a Pennsylvania corporation (the “Issuer”), held by the Funds.

     

    Item 1 (a)

    Name of Issuer.

    Safeguard Scientifics, Inc.

     

    Item 1 (b)

    Address of Issuer’s Principal Executive Offices.

    150 N. Radnor Chester Road, Suite F-200

    Radnor, PA 19087

     

    Item 2 (a)

    Name of Person Filing.

     

      (1)

    North Run Capital, LP

     

      (2)

    North Run Advisors, LLC

     

      (3)

    Todd B. Hammer

     

      (4)

    Thomas B. Ellis

     

    Item 2 (b)

    Address of Principal Business Office, or, if none, Residence.

    For all Filers:

    867 Bolyston St.

    5th Floor #1361

    Boston, MA 02116

     

    Item 2 (c)

    Citizenship or Place of Organization.

     

      (1)

    North Run Capital, LP is a Delaware limited partnership.

     

      (2)

    North Run Advisors, LLC is a Delaware limited liability company.

     

      (3)

    Todd B. Hammer is a U.S. citizen.

     

      (4)

    Thomas B. Ellis is a U.S. citizen.

     

    Item 2 (d)

    Title of Class of Securities.

    Common Stock, $0.10 par value.


    Item 2 (e)

    CUSIP Number.

    786449207

     

    Item 3

    Reporting Person.

    Inapplicable

     

    Item 4

    Ownership.

     

      (a)

    The Investment Manager, North Run, Todd B. Hammer and Thomas B. Ellis may be deemed the beneficial owners of 252,728 shares of Common Stock.

     

      (b)

    The Investment Manager, North Run, Todd B. Hammer and Thomas B. Ellis may be deemed the beneficial owners of 1.5% of the outstanding shares of Common Stock. This percentage was determined by dividing 252,728 by 16,322,214, which is the number of shares of Common Stock outstanding as of October 31, 2022, according to the Issuer’s Form 10-Q filed on November 14, 2022 with the Securities and Exchange Commission.

     

      (c)

    The Investment Manager, Todd B. Hammer and Thomas B. Ellis have the shared power to vote and dispose of the 252,728 shares of Common Stock beneficially owned.

     

    Item 5

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ☒.

     

    Item 6

    Ownership of More Than Five Percent on Behalf of Another Person.

    Inapplicable.

     

    Item 7

    Identification and Classification of the Subsidiary which Acquired the Security Being Reported On by the Parent Holding Company.

    Inapplicable

     

    Item 8

    Identification and Classification of Members of the Group.

    Inapplicable

     

    Item 9

    Notice of Dissolution of Group.

    Inapplicable

     

    Item 10

    Certification.

    By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: February 13, 2023

     

    NORTH RUN CAPITAL, LP
    By:  

    North Run Advisors, LLC

    its general partner

             By:   /s/ Thomas B. Ellis*
        Name: Thomas B. Ellis
        Title: Member
      and
      By:   /s/ Todd B. Hammer*
        Name: Todd B. Hammer
        Title: Member
    NORTH RUN ADVISORS, LLC
    By:   /s/ Thomas B. Ellis*
      Name: Thomas B. Ellis
      Title: Member
    and
    By:   /s/ Todd B. Hammer*
      Name: Todd B. Hammer
      Title: Member
    /s/ Thomas B. Ellis*
    Thomas B. Ellis
    /s/ Todd B. Hammer*
    Todd B. Hammer
    * By   /s/ MICHAEL FISHER
      Michael Fisher, Attorney-in-Fact Pursuant to Powers of Attorney filed as exhibits hereto
    Get the next $SFE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SFE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SFE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Safeguard Scientifics Filed Form 25 to Voluntarily Delist its Common Stock from The Nasdaq Stock Market LLC

      RADNOR, Pa., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") has announced today that it filed Form 25 with the Securities and Exchange Commission (the "SEC") to voluntarily delist its shares of common stock from trading on The Nasdaq Stock Market LLC ("Nasdaq") in connection with its previously announced plan to deregister its common stock under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and to delist the Company's common stock from trading on Nasdaq (referred to as the "Transaction"). The Company expects that the delisting will occur ten days after the filing of Form 25 so that trading will be suspended

      2/2/24 8:30:00 AM ET
      $SFE
      Finance/Investors Services
      Finance
    • Safeguard Scientifics Intends to File Form 25 to Voluntarily Delist its Common Stock from The Nasdaq Stock Market LLC

      Radnor, Pa, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") has announced today that it notified The Nasdaq Stock Market LLC ("Nasdaq") that it intends to file Form 25 with the Securities and Exchange Commission (the "SEC") on February 2, 2024 to voluntarily delist its shares of common stock from trading on Nasdaq in connection with its previously announced plan to deregister its common stock under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company expects that the delisting will occur ten days after the filing of Form 25, at which point, the Company intends to file a Form 15 with the SEC certifying

      1/22/24 4:30:00 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • Safeguard Scientifics Announces Effective Date of Stock Splits to Effectuate the Going Dark Transaction and New Chief Executive Officer and Chief Financial Officer

      RADNOR, Pa., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that, as authorized by its Board of Directors (the "Board"), the Company will file amendments to its articles of incorporation with the Pennsylvania Department of State to effectuate a reverse stock split at a ratio of 1-for-100, to be followed immediately by a forward stock split at a ratio of 100-for-1 (collectively referred to as "stock splits"), which are expected to become effective on or about January 12, 2024, and the Company's common stock is expected to begin trading on The Nasdaq Stock Market LLC ("Nasdaq") on a post-forward stock split basis upon

      1/5/24 4:30:00 PM ET
      $SFE
      Finance/Investors Services
      Finance

    $SFE
    Financials

    Live finance-specific insights

    See more

    $SFE
    Leadership Updates

    Live Leadership Updates

    See more

    $SFE
    SEC Filings

    See more

    $SFE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Safeguard Scientifics Announces Stock Split Ratios to Effectuate the Going Dark Transaction

      RADNOR, Pa., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that, after the Company's shareholders adopted amendments to the articles of incorporation at the Special Meeting of Shareholders held on December 15, 2023 (the "Special Meeting") to effect a reverse stock split, to be followed immediately by a forward stock split, at a ratio of (i) not less than 1-for-50 and not greater than 1-for-100, in the case of the reverse stock split, and (ii) not less than 50-for-1 and not greater than 100-for-1, in the case of the forward stock split (collectively referred to as "stock splits"), the Company's Board of Directors (t

      12/18/23 4:30:00 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • Safeguard Scientifics' Board of Directors Declares Contingent Cash Dividend of $0.35 Per Share

      RADNOR, Pa., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced that on December 7, 2023, its Board of Directors (the "Board") declared a special cash dividend of $0.35 per share, payable on December 28, 2023 to shareholders of record as of the close of business on December 19, 2023 (the "Record Date"). The dividend is contingent on the adoption of amendments to the Company's articles of incorporation effecting the reverse stock split and the forward stock split of the Company's common stock at the Special Meeting of Shareholders to be held on December 15, 2023, and the Board thereafter giving effect to the Company's

      12/8/23 4:30:00 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • Safeguard Scientifics Announces Third Quarter 2023 Financial Results

      RADNOR, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) ("Safeguard" or the "Company") today announced financial results for the three and nine months ended September 30, 2023. THIRD QUARTER 2023 HIGHLIGHTS Financial Results Cash, cash equivalents and restricted cash totaled $15.7 million at September 30, 2023.The carrying value of the Company's ownership interests totaled $14.8 million at September 30, 2023. The total cost of the Company's ownership interests was $122.8 million.Net income for the three months ended September 30, 2023 was $0.9 million, or $0.06 per basic and fully diluted share, as compared with a net loss of $3.2 million, or $0.19 per bas

      11/2/23 4:30:03 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • TheracosBio Announces the Appointments of Jim Greenwood to Board of Directors and Jeff McGroarty as Chief Financial Officer

      TheracosBio today announced the appointment of former US Congressman Jim Greenwood to the Board of Directors of its parent company and Jeff McGroarty, MBA, as its Chief Financial Officer. Congressman Greenwood is an established leader in life sciences across business and public policy, and Mr. McGroarty has served as a CFO of public and private life sciences and technology companies. Both newly appointed team members will help shape the commercial strategy for Brenzavvy™ (bexagliflozin), a recently FDA-approved treatment for type 2 diabetes. "Accomplished leaders, Jim and Jeff will be valuable members of our team at this critical time for TheracosBio," said Albert R. Collinson, Ph.D., Pres

      3/13/23 8:00:00 AM ET
      $ANVS
      $SFE
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Finance/Investors Services
      Finance
    • Safeguard Scientifics Announces Appointment Of Eric C. Salzman As CEO

      RADNOR, Pa., Dec. 21, 2020 /PRNewswire/ -- Safeguard Scientifics, Inc. (NYSE:SFE) announced today that Eric C. Salzman has been appointed Chief Executive Officer, effective December 21, 2020.  Since April 1, 2020, Mr. Salzman has served as the Company's Chief Restructuring Officer. As CEO, Mr. Salzman will continue to focus on the value maximization and monetization of Safeguard's interests in its portfolio companies as well as the management of Safeguard's operations. "Since joining Safeguard earlier this year, we have been impressed with Eric's progress towards executing on Safeguard's strategy to drive value creation from the portfolio and return capital to our shareholders," said Robe

      12/21/20 8:00:00 AM ET
      $SFE
      Finance/Investors Services
      Finance
    • SEC Form 15-12G filed by Safeguard Scientifics Inc.

      15-12G - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)

      2/20/24 3:02:10 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • SEC Form SC 13E3/A filed by Safeguard Scientifics Inc. (Amendment)

      SC 13E3/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)

      2/20/24 3:01:28 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • SEC Form EFFECT filed by Safeguard Scientifics Inc.

      EFFECT - SAFEGUARD SCIENTIFICS INC (0000086115) (Filer)

      2/20/24 12:15:21 AM ET
      $SFE
      Finance/Investors Services
      Finance
    • SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)

      SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)

      2/14/24 5:04:07 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)

      SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)

      2/14/24 4:05:40 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • SEC Form SC 13G/A filed by Safeguard Scientifics Inc. (Amendment)

      SC 13G/A - SAFEGUARD SCIENTIFICS INC (0000086115) (Subject)

      2/12/24 4:59:41 PM ET
      $SFE
      Finance/Investors Services
      Finance

    $SFE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Manko Joseph M. Jr. was granted 38,087 shares, increasing direct ownership by 20% to 232,323 units (SEC Form 4)

      4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)

      2/1/24 2:36:21 PM ET
      $SFE
      Finance/Investors Services
      Finance
    • Demont Ross D was granted 20,775 shares, increasing direct ownership by 8% to 287,256 units (SEC Form 4)

      4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)

      1/31/24 9:19:37 AM ET
      $SFE
      Finance/Investors Services
      Finance
    • Michelson Beth was granted 22,506 shares, increasing direct ownership by 22% to 126,352 units (SEC Form 4)

      4 - SAFEGUARD SCIENTIFICS INC (0000086115) (Issuer)

      1/31/24 9:09:45 AM ET
      $SFE
      Finance/Investors Services
      Finance